Shijiazhuang Yiling Pharmaceutical Co., Ltd. Share Price
Equities
002603
CNE1000015S0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.3 CNY | -1.48% | +2.50% | -16.34% |
Sales 2024 * | 11.36B 1.57B 126B | Sales 2025 * | 14.17B 1.96B 157B | Capitalization | 32.24B 4.46B 357B |
---|---|---|---|---|---|
Net income 2024 * | 1.56B 216M 17.22B | Net income 2025 * | 2.43B 337M 26.89B | EV / Sales 2024 * | 2.73 x |
Net cash position 2024 * | 1.23B 170M 13.6B | Net cash position 2025 * | 2.12B 294M 23.47B | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 * |
20.7
x | P/E ratio 2025 * |
13.3
x | Employees | 13,958 |
Yield 2024 * |
1.85% | Yield 2025 * |
2.41% | Free-Float | 41.69% |
1 day | -1.48% | ||
1 week | +2.50% | ||
Current month | +2.50% | ||
1 month | -5.02% | ||
3 months | -6.99% | ||
6 months | -14.30% | ||
Current year | -16.34% |
Managers | Title | Age | Since |
---|---|---|---|
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 31/12/04 |
Chen Guang Li
DFI | Director of Finance/CFO | 51 | 31/12/96 |
Qiu Lian Zhang
BRD | Director/Board Member | 54 | 15/03/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Ling Wu
FOU | Founder | 75 | 27/08/01 |
Xiang Jun Wu
CEO | Chief Executive Officer | 49 | 31/12/04 |
Chen Guang Li
DFI | Director of Finance/CFO | 51 | 31/12/96 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.90% | 0 M€ | -12.22% | - | |
0.66% | 4 M€ | -2.96% | ||
0.57% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 19.3 | -1.48% | 12,745,640 |
09/05/24 | 19.59 | +2.03% | 17,593,490 |
08/05/24 | 19.2 | -1.44% | 12,609,740 |
07/05/24 | 19.48 | +0.52% | 13,494,980 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.34% | 4.46B | |
+40.09% | 6.16B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B | |
+48.97% | 1.54B |
- Stock Market
- Equities
- 002603 Stock